Source link : https://www.newshealth.biz/health-news/pembrolizumab-plus-ccrt-improves-overall-survival/
BARCELONA, Spain — Adding pembrolizumab to standard concurrent chemoradiotherapy (CCRT) significantly improves overall survival in patients with high-risk, locally advanced cervical cancer, according to results of a phase 3, randomized, double-blind trial. Domenica Lorusso, MD, PhD, director of Gynecological Oncology at Humanitas San Pio X and professor at Humanitas University, Milan, Italy, presented these findings […]
Author : News Health
Publish date : 2024-09-17 10:58:54
Copyright for syndicated content belongs to the linked Source.